Lotte Langkjær

505 total citations
10 papers, 393 citations indexed

About

Lotte Langkjær is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Lotte Langkjær has authored 10 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Lotte Langkjær's work include Diabetes Management and Research (6 papers), Pancreatic function and diabetes (5 papers) and Diabetes Treatment and Management (2 papers). Lotte Langkjær is often cited by papers focused on Diabetes Management and Research (6 papers), Pancreatic function and diabetes (5 papers) and Diabetes Treatment and Management (2 papers). Lotte Langkjær collaborates with scholars based in Denmark, France and United States. Lotte Langkjær's co-authors include Jens Brange, Jan Markussen, Philip Hougaard, Richard H. Guy, Christian Poulsen, Kjeld Norris, A.R. Sørensen, Allan Vaag, Finn Stener Jørgensen and L. Snel and has published in prestigious journals such as Journal of Controlled Release, Protein Engineering Design and Selection and Diabetes Technology & Therapeutics.

In The Last Decade

Lotte Langkjær

10 papers receiving 376 citations

Peers

Countries citing papers authored by Lotte Langkjær

Since Specialization

Citations

This map shows the geographic impact of Lotte Langkjær's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotte Langkjær with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotte Langkjær more than expected).

Fields of papers citing papers by Lotte Langkjær

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotte Langkjær. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotte Langkjær. The network helps show where Lotte Langkjær may publish in the future.

Co-authorship network of co-authors of Lotte Langkjær

This figure shows the co-authorship network connecting the top 25 collaborators of Lotte Langkjær. A scholar is included among the top collaborators of Lotte Langkjær based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotte Langkjær. Lotte Langkjær is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Precipitation of Insulin Aspart and Insulin Glulisine Products Used for Continuous Subcutaneous Insulin Infusion 2007 ·Diabetes Technology & Therapeutics ·Christian Poulsen, Lotte Langkjær, (unknown)	16
2	Precipitation of Insulin Products Used for Continuous Subcutaneous Insulin Infusion 2005 ·Diabetes Technology & Therapeutics ·Christian Poulsen, Lotte Langkjær, (unknown)	28
3	Insulin Formulation and Delivery 2002 ·Pharmaceutical biotechnology ·Jens Brange, Lotte Langkjær	36
4	Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment 1998 ·Journal of Controlled Release ·Lotte Langkjær, Jens Brange, (unknown), Richard H. Guy	61
5	Application of the euglycaemic clamp technique to bioassay of insulin analogues 1992 ·Biologicals ·(unknown), Ulla Ribel, (unknown), J. Markussen, Lotte Langkjær, J. Dolben, David R. Owens	2
6	Chemical stability of insulin. 3. Influence of excipients, formulation, and pH. 1992 ·PubMed ·Jens Brange, Lotte Langkjær	71
7	Insulin analogues with improved absorption characteristics. 1992 ·PubMed ·Jens Brange, J. F. Hansen, Lotte Langkjær, J. Markussen, Ulla Ribel, (unknown)	6
8	NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue. 1989 ·BMJ ·Finn Stener Jørgensen, Allan Vaag, Lotte Langkjær, Philip Hougaard, Jan Markussen	48
9	Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30 1988 ·Protein Engineering Design and Selection ·Jan Markussen, (unknown), Philip Hougaard, Lotte Langkjær, Kjeld Norris, L. Snel, A.R. Sørensen, (unknown), (unknown)	74
10	Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30 1987 ·Protein Engineering Design and Selection ·Jan Markussen, (unknown), (unknown), Mogens Trier Hansen, Philip Hougaard, Lotte Langkjær, Kjeld Norris, Ulla Ribel, A.R. Sørensen, (unknown)	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact